Wednesday, January 17, 2018
Insurance Journal-Jan 16, 2018
On June 16, 2017, DWC announced an informal draft rule to require that compounded drugs be preauthorized. The rule was drafted at the request of the legislature after a DWC study found that the cost of compounded drugs doubled from 2010-2014, and the average cost per prescription had risen to $829 in 2016.
Reuters-19 hours ago
Jan 16 (Reuters) - The U.S. Food and Drug Administration has issued a warning letter to Imprimis Pharmaceuticals Inc accusing it of making false or misleading claims that its compounded eye medications had the agency's approval. The Dec. 21 letter to San Diego-based Imprimis was posted on the FDA's website on ...